logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Benefit of aggressive lipid-lowering therapy : Insights from the Post Coronary Artery Bypass Graft Study and other trials.

    Article, Communication - En anglais

    Western Working Group Consensus Conference. Maui, HI, USA, 1997/11/20.

    The importance of treating patients to lower cholesterol levels to lessen the risk of developing atherosclerosis is well accepted.

    However, the benefits of aggressive treatment for lowering low-density lipoprotein (LDL) cholesterol and a defined threshold at which lowering cholesterol is of little use are still questionable.

    Although definitive answers are still not available, interesting data come from follow-ups and reviews of epidemiologic and clinical trials completed decades ago.

    In the Seven Countries Study, a 25-year follow-up shows that while absolute levels of coronary artery disease mortality differed by geographic area, the relative increase in mortality due to a given increase in cholesterol was similar in all cultures except Japan.

    A new look at the Framingham Study reveals that mean serum cholesterol of persons developing coronary disease has been decreasing progressively for the last 3 decades.

    Most recently, average levels of total serum cholesterol and LDL cholesterol for men are below the levels now recommended for treatment according to the National Cholesterol Education Program guidelines.

    Clinical and angiographic intervention trials have now ascertained that lowering LDL cholesterol is effective in prevention and in secondary treatment of coronary atherosclerosis. (...)

    Mots-clés Pascal : Cardiopathie coronaire, Dérivation, Homogreffe, Cholestérol LDL, Essai thérapeutique contrôlé, Dose forte, Angiographie, Postopératoire, Efficacité traitement, Recommandation, Homme, Epidémiologie, Appareil circulatoire pathologie, Greffe, Radiodiagnostic

    Mots-clés Pascal anglais : Coronary heart disease, Bypass, Homograft, Cholesterol LDL, Controlled therapeutic trial, High dose, Angiography, Postoperative, Treatment efficiency, Recommendation, Human, Epidemiology, Cardiovascular disease, Graft, Radiodiagnosis

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0051944

    Code Inist : 002B02N. Création : 31/05/1999.